Lyxor STOXX Europe 600 Healthcare

European healthcare companies

(CH5)
£120.07
Previous business day’s close price
£12.81 (‑9.64%)
max available period
£119.48
£140.79

05 Jun 24
20 Nov 24

Details

ETF description

This ETF focuses on investing in a diversified range of companies within the healthcare sector across Europe. By investing in this ETF, investors gain exposure to various healthcare‑related businesses, such as pharmaceuticals, biotechnology, medical equipment, and healthcare providers.

This type of investment may appeal to investors looking to diversify their portfolio with European healthcare stocks, potentially benefiting from the growth and stability often associated with this sector.

Issuer details

Amundi Asset Management is the largest asset manager in Europe, with over €2 trillion in assets under management as of June 2024. Amundi offers a comprehensive range of investment products, including ETFs, mutual funds, active management, and alternative investments, covering a wide array of market segments such as equities, fixed income, multi‑asset, alternatives, and ESG (Environmental, Social, Governance). Founded in 2010 through the merger of the asset management arms of Crédit Agricole and Société Générale, Amundi has a strong commitment to ESG investing and innovation, striving to deliver cost‑efficient solutions to its clients. With an extensive global presence, Amundi’s notable ETFs include the Amundi MSCI World UCITS ETF and the Amundi Prime Global UCITS ETF, highlighting its dedication to providing diversified and sustainable investment options.

Index details

The MSCI Europe Healthcare index offers targeted exposure to healthcare companies across Europe, encompassing a diverse range of firms within the healthcare sector. By focusing on businesses involved in pharmaceuticals, biotechnology, medical devices, and healthcare services, this index provides investors with a comprehensive view of the European healthcare landscape. Its sector‑specific focus makes it a valuable addition for portfolios seeking to capitalize on growth opportunities and innovations within the European healthcare market.

This ETF is in collections:

ETF Breakdown

Novo Nordisk As Class B
19.6%
Novartis AG
11.9%
Roche Holding AG
11.9%
Astrazeneca plc
11.4%
Sanofi
6.5%
GSK Plc
4.3%
EssilorLuxottica
4.2%
Lonza Group AG
2.6%
Alcon
2.5%
argenx SE
2.1%
Others
22.9%
£120.07
Previous business day’s close price

Capital at risk

Why InvestEngine

Unbeatable value

From commission‑free investing, to zero‑ISA fees, we’re proud of our low fees.
Here's how we're able to do it

Choice of 700+ ETFs

Low cost, diversified, index‑tracking of stock markets, bonds and commodities.
Browse investments

Actionable insights

Know exactly which companies, sectors and regions are in your portfolio.

Powerful automation

Grow your wealth the easy way with automated investing features

Easy diversification

Fractional investing lets you put as little as £1 in any ETF.

DIY or Managed

Build and manage your own portfolio or leave it to us.

ETFs have spreads and annual charges and come with risks like market volatility, liquidity, and concentration, and may not always accurately track their index. Past performance and forecasts are not reliable indicators of future results. The value of your investments, including any income, can rise or fall. You may get back less than you originally invested.
Whenever you invest, your capital is at risk
This could mean the value of your investments goes down as well as up.
Understand more about investment risk.
© InvestEngine Limited 2024. All rights reserved.